SecBot SecBot

ARDT

Ardent Health, Inc.
NYSE· Services-General Medical & Surgical Hospitals, NEC· Inc. DE· CIK 0001756655 Healthcare & Medical Devices
$12.25 +0.07 (+0.57%)
Oct 27 4:00 PM ET · prev $12.18
Market cap
$1.7B
Small cap
Consensus
Buy
63% Buy or better · 19 analysts
Median target
$13.00
+6% · range $10.50–14.00
Next earnings
Nov 4
in 8 days
1 year
−19.1%
from $15.14 · Oct 27
30 days
+17.0%
from $10.47
52-week range
$7.83–15.14
−19% from high · low Jun 3
Avg volume 20D
449.8K
shares / day
Short interest
🔒 Subscribers only
Insider net
+$186.4K
2 buyers · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
9
analyzed by SecBot
SecBot read BEARISH 3 reports · 90 days
Balance 1 bearish · 1 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 2/3 ·Next Earnings date, Nov 4, 2026
Strongest BEARISH Ardent Health's Board recharacterized former CEO Martin Bonick's departure as a termination for Cause…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    2 insiders bought $186.4K at an average $8.77. No open-market sales. Price is 40% above their cost.

  • InstitutionsBULLISH

    Q2 2026: 26 added (0 new), 11 trimmed or exited.

  • AnalystsBULLISH

    12 of 19 rate it Buy or better. Median target $13.00 (+6%).

  • TrendUPTREND

    10% above its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
AMERICAN CENTURY COMPANIES INCDOUBLED309,359$3.0M
GOLDMAN SACHS GROUP INCADD304,449$3.0M
JANE STREET GROUP, LLCADD300,343$3.0M
JPMORGAN CHASE & COADD242,329$2.4M
VANGUARD PORTFOLIO MANAGEMENT LLCTRIM208,217$2.0M
CITADEL ADVISORS LLCTRIM113,495$1.1M
Vanguard Global Advisers, LLCTRIM113,421$1.1M
JACOBS LEVY EQUITY MANAGEMENT, INCDOUBLED105,632$1.0M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

19 analysts
Buy 63% rate it Buy or better
Strong Buy5Buy7Hold6Sell1Strong Sell0
12-month targets · 12 analysts

Price is inside the target range. Median implies +6%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Sep 23, 2026BMO Capital
INITIATE
INITIATEMarket Perform
Sep 18, 2026Leerink Partners
MAINTAIN
MAINTAINOutperform
Aug 10, 2026RBC Capital
MAINTAIN
MAINTAINOutperform
Aug 6, 2026Truist Securities
MAINTAIN
MAINTAINBuy
Aug 6, 2026Guggenheim
MAINTAIN
MAINTAINBuy
Jul 14, 2026Truist Securities
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$186.4K
bought · 2 insiders
$0
sold · 0 insiders
+39.7%
vs their $8.77 cost
DateInsiderTypeValue
Sep 25, 2026
Byers David Raynor
SVP & Chief Accounting Officer
TAX W/H$5.5K
Sep 25, 2026
Petrovich Stephen C.
EVP, GC and Secretary
TAX W/H$8.3K
Sep 25, 2026
LUMSDAINE ALFRED
Chief Financial Officer
TAX W/H$35.7K
Jul 1, 2026
Caspers Dave
CEO and President
AWARD103,653 sh
Jun 5, 2026
DeMichiei Robert
Director
BUY$98.3K
Jun 5, 2026
LUMSDAINE ALFRED
Chief Financial Officer
BUY$88.1K
Apr 1, 2026
Bonick Martin
President and CEO
AWARD134,615 sh
Apr 1, 2026
Byers David Raynor
SVP & Chief Accounting Officer
TAX W/H$8.0K

Earnings setup

Estimates
Nov 4
reports in 8 days

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 23, 2026 SEC
Ardent Health's Board recharacterized former CEO Martin Bonick's departure as a termination for Cause, citing failure…
8-K — Impact 5/10
Sep 25, 2026 Insider
Byers David Raynor surrendered for taxes 524 shares
SVP & Chief Accounting Officer @ $10.54 ($5.5K)
Sep 25, 2026 Insider
Petrovich Stephen C. surrendered for taxes 788 shares
EVP, GC and Secretary @ $10.54 ($8.3K)
Sep 25, 2026 Insider
LUMSDAINE ALFRED surrendered for taxes 3,389 shares
Chief Financial Officer @ $10.54 ($35.7K)
Aug 20, 2026 SEC
Martin Bonick, a former officer and director of Ardent Health, filed a Form 144 notice of intent to sell 35,930 shares…
144 — Impact 2/10
Aug 15, 2026 SEC
A significant institutional cluster formed in Ardent Health (ARDT) during Q2 2026, with 7 buyers adding $6.2M in net…
INST-CLUSTER — Impact 5/10
Aug 4, 2026 Earnings calendar
ARDT Q2 2026 Earnings Scheduled — 2026-08-04
Jun 30, 2026 Inst.
AMERICAN CENTURY COMPANIES INC — DOUBLED
309,359 shares ($3.0M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 4, 2026
Earnings date
ARDT Q3 2026 Earnings Scheduled — 2026-11-04
Recent
Aug 4, 2026
Earnings date
ARDT Q2 2026 Earnings Scheduled — 2026-08-04
Jun 30, 2026
Short interest
Short Interest: ARDT up 24% to 4.5M shares
Settlement 2026-06-30 | Days to cover: 7.46 | ≈3.13% of shares outstanding (est.)
Jun 15, 2026
Short interest
Short Interest: ARDT up 20% to 3.6M shares
Settlement 2026-06-15 | Days to cover: 4.79 | ≈2.54% of shares outstanding (est.)
May 5, 2026
Earnings date
ARDT Q1 2026 Earnings Scheduled — 2026-05-05
Mar 4, 2026
Earnings date
ARDT Q4 2025 Earnings Scheduled — 2026-03-04

SecBot reports

9 filings · 2 bullish · 1 bearish · 2 mixed · 4 neutral
All ARDT filing & press-release reports (9)